Mirae Asset Healthcare Fund Direct Growth
Equity
Direct
Sector - Healthcare
NAV as on 21-11-2024
₹ 40.74
▲0.8%
1D
Inception Returns
24.2%
/yr
About Mirae Asset Healthcare Fund Direct Growth
Mirae Asset Healthcare Fund Direct Growth is an equity fund. This fund was started on 2 June, 2018. The fund is managed by Vrijesh Kasera. The fund could potentially beat inflation in the long-run.
Key Parameters
- Mirae Asset Healthcare Fund Direct Growth has ₹2770 Cr worth of assets under management (AUM) as on Oct 2024 and is more than category average.
- The fund has an expense ratio 0.5.
Returns
Mirae Asset Healthcare Fund Direct Growth has given a CAGR return of 24.24% since inception. Over the last 1, 3 and 5 years the fund has given a CAGR return of 39.53%, 18.64% and 30.23% respectively.
Holdings
Mirae Asset Healthcare Fund Direct Growth has allocated its funds majorly in Cash Equivalent, Health, Basic Materials. Its top holdings are Sun Pharmaceuticals Industries Ltd, Aurobindo Pharma Ltd, Cipla Ltd, Glenmark Pharmaceuticals Ltd, Dr Reddy's Laboratories Ltd
Taxation
As it is a sector - healthcare mutual fund the taxation is as follows:For short term (less than a year) capital gains will be taxed at 15%For long term (more than 1 year) capital gains will be taxed at 10% without indexation benefitDividends will always be taxed at slab rate. Gains upto Rs 1 lakh are exempt in case of long term.
Investment objective of Mirae Asset Healthcare Fund Direct Growth
The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India. The Scheme does not guarantee or assure any returns.
Minimum Investment and lockin period
Minimum investment for lump sum payment is INR 5000.00 and for SIP is INR 99.00. Mirae Asset Healthcare Fund Direct Growth has no lock in period.
Historical NAV & Returns
Annualised
▲
▼
2908 people have invested ₹ 2.6Cr in Mirae Asset Healthcare Fund Direct Growth in the last three months
INDmoney Rank for Mirae Asset Healthcare Fund Direct Growth
Powered by IND quant engine
IND ranking is not available for this fund.
5Y returns in the top 25% of the category
Lower expense ratio
Beats FD returns for both 3Y & 5Y duration
3Y returns in the bottom 25% of the category
Mirae Asset Healthcare Fund Direct Growth Overview
| Expense ratio | 0.49% |
Benchmark | S&P BSE Healthcare PR |
| AUM | ₹2770 Cr |
| Inception Date | 2 June, 2018 |
| Min Lumpsum/SIP | ₹5000/₹99 |
Exit Load | 1.0% |
| Lock In | No Lock-in |
TurnOver | 18.15% |
| STCG | Redeeming before 1 year, returns taxed at 20%. |
| LTCG | After 1 year, 12.5% tax on returns over ₹1.25 lakh/year. |
| Risk |   Very High Risk |
Trailing Returns
as on (21-Nov-24)
Fund Distribution
as on (31-Oct-24)
Large cap
43.9%
Mid cap
34.9%
Small cap
18.7%
Sector Allocation
Health
98.6%
Basic Materials
1.4%
All changes are between Aug'24 and Oct'24
- This fund’s returns stands at -1.20% whereas the fund’s underlying benchmark Nifty 500 returns stands at -6.52% as on Oct'24
- This fund outperformed Nifty 500 by 5.32% in Oct'24
- AUM of the fund stands at 2.8K Cr as of Oct'24
- AUM decreased by 23.4 Cr between Oct'24 and Sep'24
Top Stocks bought last month
Glenmark Pharmaceuticals Ltd's allocation increased from 5.52% to 6.2%
Suven Pharmaceuticals Ltd's allocation increased from 3.58% to 4.22%
Wockhardt Ltd's allocation increased from 1.69% to 2.11%
Top Stocks sold last month
Sun Pharmaceuticals Industries Ltd's allocation decreased from 12.4 % to 12 %
Aurobindo Pharma Ltd's allocation decreased from 8.35 % to 8.05 %
Cipla Ltd's allocation decreased from 7.02 % to 6.8 %
Mid Cap allocation has gone down from 35.7% to 34.9%
Large Cap allocation has gone down from 44.9% to 43.9%
Small Cap allocation has gone up from 17.5% to 18.7%
Cash allocation has gone up from 0.3% to 0.9%
Top 2 Sectors in October were Health, Basic Materials
Oct'24
Health
99%
Basic Materials
1%
Sep'24
Health
99%
Basic Materials
1%
See all
Top Growth Drivers | 1M Return |
|---|---|
 Wockhardt Ltd | 11.1% |
 Suven Pharmaceuticals Ltd | 0.2% |
Loading...
We are taking more time than usual
Vrijesh Kasera
Fund Manager of Mirae Asset Healthcare Fund Direct Growth, since 2 July 2018
Top funds managed
Fund House
Mirae Asset Investment Managers (India) Private Limited
Total Schemes
Total AUM
₹1.89L Cr
as on 31-Oct-2024
Address
Mirae Asset Investment Managers (India) Private Limited.,Unit No. 606, 6th Floor,,Windsor Bldg, Off CST Road,,Kalina, Santacruz (East), Mumbai - 400 098
Phone
91-22-22-6780300
Website
customercare@miraeasset.com
Mutual Fund Insights
In the last 5 years, DSP Healthcare Fund Direct Growth has given 32.68% return, outperforming this fund by 2.45% per annum.
Over the last 15 months, this fund has decreased expense ratio by 16.9% moving from 0.59 to 0.49.
Over the last 6 months, this fund has experienced a 23.9% growth in AUM moving from 2.23K Cr to 2.77K Cr.
In the last 3 years, SBI Healthcare Opportunities Fund Direct Growth has given 24.27% return, outperforming this fund by 5.63% per annum.
This fund has one of the lowest expense ratio in the category (sector - healthcare). Its expense ratio is 0.49% which is lower than the category average expense ratio of 1.39%.
In the last 1 year, HDFC Pharma and Healthcare Fund Direct Growth has given 52.89% return, outperforming this fund by 13.36%.
Mirae Asset Healthcare Fund Direct Growth Highlights
Very High Risk
Investors understand that their principal will be at Very High Risk
About the fund
This fund has delivered an average annual returns of 24.24% since inception which is less than its category average return of 24.96%
Fund Allocations
This fund has an allocation of 99.08% in Equity, 0% in Debt and 0.91% in Cash related instruments
AUM size ₹2770 Cr
This fund has AUM of ₹2770 Cr which is more than its category average of ₹ 2001 Cr
Expense Ratio 0.49%
This fund has an expense ratio of 0.49% which is less than its category average expense ratio of 1.33%
Frequently Asked Questions for Mirae Asset Healthcare Fund Direct Growth
The current NAV of Mirae Asset Healthcare Fund Direct Growth is ₹40.74 as on 21-Nov-2024.
Existing (Absolute + CAGR) as on 21-Nov-2024.
Mirae Asset Healthcare Fund Direct Growth | Absolute Returns | CAGR Returns |
1 Month Returns | -5.82% | -5.82% |
6 Month Returns | 19.06% | 19.06% |
1 Year Returns | 39.53% | 39.53% |
3 Years Returns | 66.98% | 18.64% |
5 Years Returns | 274.64% | 30.23% |
With INDmoney, the process of investing is very simple and involves zero commission.
- Click Buy on the fund name.
- Input the amount you are looking to invest.
- Select Lump Sum or SIP (Weekly, Monthly or Quarterly).
- Select your bank account and proceed with Payment.
0.49% as on October 2024
₹2770 Cr as on October 2024
Sun Pharmaceuticals Industries Ltd(12%), Aurobindo Pharma Ltd(8.05%), Cipla Ltd(6.8%), Glenmark Pharmaceuticals Ltd(6.2%), Dr Reddy's Laboratories Ltd(6.05%) as on October 2024
The alpha ratio for the Mirae Asset Healthcare Fund Direct Growth for various period is as follows:
Fund Name | Alpha 1 Year | Alpha 3 Years | Alpha 5 Years |
Mirae Asset Healthcare Fund Direct Growth | -2.43 | 0.24 | 3.44 |
As on October 2024
The alpha for Mirae Asset Healthcare Fund Direct Growth is calculated against S&P BSE Healthcare PR. Higher alpha indicates that this fund has generated extra returns compared to the benchmark index. An alpha of 1.0 means the fund has outperformed its benchmark index by 1%.
The Beta ratio for the Mirae Asset Healthcare Fund Direct Growth for various period is as follows:
Fund Name | Beta 1 Year | Beta 3 Years | Beta 5 Years |
Mirae Asset Healthcare Fund Direct Growth | 0.99 | 0.96 | 0.96 |
As on October 2024
The Beta for Mirae Asset Healthcare Fund Direct Growth is calculated with S&P BSE Healthcare PR. Beta tells the volatility of the mutual fund relative to its benchmark. If the beta of a mutual fund is more than 1, then the mutual fund is more volatile than its benchmark. If beta is less than 1, then the mutual fund is less volatile than the benchmark.
The sharpe ratio for the Mirae Asset Healthcare Fund Direct Growth for various period is as follows:
Fund Name | Sharpe Ratio 1 Year | Sharpe Ratio 3 Years | Sharpe Ratio 5 Years |
Mirae Asset Healthcare Fund Direct Growth | 2.77 | 0.93 | 1.26 |
As on October 2024
The sharpe ratio for Mirae Asset Healthcare Fund Direct Growth is calculated with S&P BSE Healthcare PR. Sharpe ratio tells risk-adjusted-returns of the mutual fund. The higher a fund's Sharpe ratio, the better a fund's returns have been relative to the risk it has taken on.
The standard deviation for the Mirae Asset Healthcare Fund Direct Growth for various period is as follows:
Fund Name | Standard Deviation 1 Year | Standard Deviation 3 Years | Standard Deviation 5 Years |
Mirae Asset Healthcare Fund Direct Growth | 14.56 | 15.74 | 19.23 |
As on October 2024
Standard deviation tells the volatility of the returns of the mutual fund. The higher a fund's Standard deviation, the higher the volatility of the fund's returns.
Sortino ratio is 1.76 as on October 2024. Sortino ratio tells the downside risk-adjusted-returns of the mutual fund.
Vrijesh Kasera is the fund manager of Mirae Asset Healthcare Fund Direct Growth
The Exit load of Mirae Asset Healthcare Fund Direct Growth is 1%